Expert Opinion on Therapeutic Targets

, volume 26 , issue 4 , pages 375-388

Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity

Ming-Hsien CHIEN ^{1, 2, 3, 4}

Pei-Chun Shih ⁵

Yi-Fang Ding ^{6, 7}

Li-Hsin Chen ¹

Feng-Koo Hsieh ⁸

Meng-Ying Tsai ^{9, 10}

Pei Yi Li ¹¹

Chiao-Wen Lin ^{11, 12}

Shun-Fa Yang ^{9, 10}

Hide authors affiliations Show authors affiliations: 12 affiliations

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan |

TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan |

Pulmonary Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan |

⁴

Traditional Herbal Medicine Research Center, Taipei Medical University Hospital Taipei, Taiwan |

⁵

Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan |

⁶

Graduate Institute of Medical Sciences, College of Medicine, Taipei medical University, Taipei, Taiwan |

⁷

Department of Otolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan |

⁸

Department of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA |

⁹

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan |

¹⁰

Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan |

¹¹

Graduate Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan |

¹²

Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan |

Publication type: Journal Article

Publication date: 2022-04-03

Taylor & Francis

Expert Opinion on Therapeutic Targets

scimago Q1

wos Q1

SJR: 1.255

CiteScore: 7.2

Impact factor: 4.4

ISSN: 14728222, 17447631

DOI: 10.1080/14728222.2022.2061349

Copy DOI

PubMed ID: 35361044

Drug Discovery

Pharmacology

Clinical Biochemistry

Molecular Medicine

Found

Top-30

Journals

	1 2 3
Journal of Cellular and Molecular Medicine	Journal of Cellular and Molecular Medicine, 3, 12% Journal of Cellular and Molecular Medicine 3 publications, 12%
American Journal of Chinese Medicine	American Journal of Chinese Medicine, 2, 8% American Journal of Chinese Medicine 2 publications, 8%
Cancers	Cancers, 2, 8% Cancers 2 publications, 8%
Environmental Toxicology	Environmental Toxicology, 2, 8% Environmental Toxicology 2 publications, 8%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 1, 4% International Journal of Molecular Sciences 1 publication, 4%
Environmental Research	Environmental Research, 1, 4% Environmental Research 1 publication, 4%
Phytomedicine	Phytomedicine, 1, 4% Phytomedicine 1 publication, 4%
Journal of Functional Foods	Journal of Functional Foods, 1, 4% Journal of Functional Foods 1 publication, 4%
Journal of Neurochemistry	Journal of Neurochemistry, 1, 4% Journal of Neurochemistry 1 publication, 4%
Molecules	Molecules, 1, 4% Molecules 1 publication, 4%
Pharmacognosy Magazine	Pharmacognosy Magazine, 1, 4% Pharmacognosy Magazine 1 publication, 4%
Oral Oncology	Oral Oncology, 1, 4% Oral Oncology 1 publication, 4%
ACS Pharmacology & Translational Science	ACS Pharmacology & Translational Science, 1, 4% ACS Pharmacology & Translational Science 1 publication, 4%
Medicine (United States)	Medicine (United States), 1, 4% Medicine (United States) 1 publication, 4%
Discover Oncology	Discover Oncology, 1, 4% Discover Oncology 1 publication, 4%
Anti-Cancer Agents in Medicinal Chemistry	Anti-Cancer Agents in Medicinal Chemistry, 1, 4% Anti-Cancer Agents in Medicinal Chemistry 1 publication, 4%
Cell Cycle	Cell Cycle, 1, 4% Cell Cycle 1 publication, 4%
Journal of Nanoparticle Research	Journal of Nanoparticle Research, 1, 4% Journal of Nanoparticle Research 1 publication, 4%
Russian Chemical Reviews	Russian Chemical Reviews, 1, 4% Russian Chemical Reviews 1 publication, 4%
Advanced Biology	Advanced Biology, 1, 4% Advanced Biology 1 publication, 4%
	1 2 3

Publishers

	1 2 3 4 5 6 7
Wiley	Wiley, 7, 28% Wiley 7 publications, 28%
MDPI	MDPI, 4, 16% MDPI 4 publications, 16%
Elsevier	Elsevier, 4, 16% Elsevier 4 publications, 16%
World Scientific	World Scientific, 2, 8% World Scientific 2 publications, 8%
Springer Nature	Springer Nature, 2, 8% Springer Nature 2 publications, 8%
SAGE	SAGE, 1, 4% SAGE 1 publication, 4%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 4% American Chemical Society (ACS) 1 publication, 4%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 1, 4% Ovid Technologies (Wolters Kluwer Health) 1 publication, 4%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 1, 4% Bentham Science Publishers Ltd. 1 publication, 4%
Taylor & Francis	Taylor & Francis, 1, 4% Taylor & Francis 1 publication, 4%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii	Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii, 1, 4% Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii 1 publication, 4%
	1 2 3 4 5 6 7

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

CHIEN M. et al. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity // Expert Opinion on Therapeutic Targets. 2022. Vol. 26. No. 4. pp. 375-388.

GOST all authors (up to 50) Copy

CHIEN M., Shih P., Ding Y., Chen L., Hsieh F., Tsai M., Li P. Y., Lin C., Yang S. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity // Expert Opinion on Therapeutic Targets. 2022. Vol. 26. No. 4. pp. 375-388.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1080/14728222.2022.2061349

UR - https://doi.org/10.1080/14728222.2022.2061349

TI - Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity

T2 - Expert Opinion on Therapeutic Targets

AU - CHIEN, Ming-Hsien

AU - Shih, Pei-Chun

AU - Ding, Yi-Fang

AU - Chen, Li-Hsin

AU - Hsieh, Feng-Koo

AU - Tsai, Meng-Ying

AU - Li, Pei Yi

AU - Lin, Chiao-Wen

AU - Yang, Shun-Fa

PY - 2022

DA - 2022/04/03

PB - Taylor & Francis

SP - 375-388

IS - 4

VL - 26

PMID - 35361044

SN - 1472-8222

SN - 1744-7631

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2022_CHIEN,

author = {Ming-Hsien CHIEN and Pei-Chun Shih and Yi-Fang Ding and Li-Hsin Chen and Feng-Koo Hsieh and Meng-Ying Tsai and Pei Yi Li and Chiao-Wen Lin and Shun-Fa Yang},

title = {Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity},

journal = {Expert Opinion on Therapeutic Targets},

year = {2022},

volume = {26},

publisher = {Taylor & Francis},

month = {apr},

url = {https://doi.org/10.1080/14728222.2022.2061349},

number = {4},

pages = {375--388},

doi = {10.1080/14728222.2022.2061349}

}

MLA

Cite this

MLA Copy

CHIEN, Ming-Hsien, et al. “Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity.” Expert Opinion on Therapeutic Targets, vol. 26, no. 4, Apr. 2022, pp. 375-388. https://doi.org/10.1080/14728222.2022.2061349.

Publisher

Taylor & Francis

Journal

Expert Opinion on Therapeutic Targets

scimago Q1

wos Q1

SJR

1.255

CiteScore

7.2

Impact factor

4.4

ISSN

14728222 (Print)

17447631 (Electronic)